Search Results for: IL4R

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
DOK2 docking protein 2
  • Tie2 Signaling
  • RET signaling
IL13 interleukin 13
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-18 signaling
  • Cintredekin Besudotox
  • Lebrikizumab
  • Asthma
  • Graft-versus-host disease
IL4 interleukin 4
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-18 signaling
  • Pascolizumab
  • Asthma
SOCS5 suppressor of cytokine signaling 5
  • Interleukin-4 and Interleukin-13 signaling
  • Neddylation
ARIH2 ariadne RBR E3 ubiquitin protein ligase 2
  • Antigen processing: Ubiquitination & Proteasome degradation
IL13RA1 interleukin 13 receptor subunit alpha 1
  • Interleukin-4 and Interleukin-13 signaling
IL13RA2 interleukin 13 receptor subunit alpha 2
  • Interleukin-4 and Interleukin-13 signaling
  • AER001
CD40 CD40 molecule
  • Lucatumumab
  • Dacetuzumab
  • Hyper IgM syndromes, autosomal recessive type, including the following three diseases: Activation-induced cytidine deaminase (AICD) defect; Uracil nucleotide glycoside glycosylase (UNG) defect; Immunodeficiency with hyper-IgM type 3
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency

Page 2 out of 2 pages